Apexigen, Inc.
APGN · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2 | $3 | $4 | $6 |
| G&A Expenses | $4 | $3 | $2 | $3 |
| SG&A Expenses | $4 | $3 | $2 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $6 | $7 | $9 |
| Operating Income | -$6 | -$6 | -$7 | -$9 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$6 | -$6 | -$6 | -$8 |
| Tax Expense | $0 | -$0 | $0 | -$0 |
| Net Income | -$6 | -$6 | -$7 | -$8 |
| % Margin | – | – | – | – |
| EPS | -0.24 | -0.24 | -330.41 | -0.4 |
| % Growth | 0% | 99.9% | -82,502.5% | – |
| EPS Diluted | -0.24 | -0.24 | -330.41 | -0.4 |
| Weighted Avg Shares Out | 25 | 24 | 0 | 20 |
| Weighted Avg Shares Out Dil | 25 | 24 | 0 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$6 | -$14 | -$9 |
| % Margin | – | – | – | – |